» Articles » PMID: 17157785

Radiation Resistance and Stem-like Cells in Brain Tumors

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2006 Dec 13
PMID 17157785
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

The concepts of stem cells being resistant to therapy, stem-like cells existing in brain tumors, and these tumors initially responding to therapy followed by recurrence are well documented. On this foundation, a recent paper in Nature has demonstrated that CD133-expressing glioma cells in vivo and in culture are relatively resistant to radiation. The mechanism of resistance involves the cell-cycle-regulating proteins CHK1/CHK2. The data raise many questions about the details of radiobiology of stem-like cells in their native environment within tumors in vivo. These answers may lead to better optimization of radiation treatments and schedules for these patients.

Citing Articles

Metal-Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy.

Wang G, Wang D, Xia L, Lian J, Zhang Q, Shen D ACS Appl Mater Interfaces. 2025; 17(5):7478-7488.

PMID: 39871538 PMC: 11803545. DOI: 10.1021/acsami.4c21028.


CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas.

Qi L, Du Y, Huang Y, Kogiso M, Zhang H, Xiao S Br J Cancer. 2024; 131(2):258-270.

PMID: 38834745 PMC: 11263392. DOI: 10.1038/s41416-024-02724-5.


Advances in Glioblastoma Therapy: An Update on Current Approaches.

Angom R, Nakka N, Bhattacharya S Brain Sci. 2023; 13(11).

PMID: 38002496 PMC: 10669378. DOI: 10.3390/brainsci13111536.


Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11.

Tallman M, Zalenski A, Stabl I, Schrock M, Kollin L, de Jong E Cancers (Basel). 2023; 15(12).

PMID: 37370783 PMC: 10296095. DOI: 10.3390/cancers15123173.


Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment.

Kilmister E, Koh S, Weth F, Gray C, Tan S Biomedicines. 2022; 10(11).

PMID: 36428556 PMC: 9687343. DOI: 10.3390/biomedicines10112988.